0,736  0,005  Stroke treatment
0,710  0,003  NMDA receptor antagonist
0,639  0,005  Acute neurologic disorders treatment
0,652  0,019  Analgesic
0,630  0,004  Dual specificity phosphatase inhibitor
0,602  0,004  Glutamate receptor antagonist
0,597  0,015  Cognition disorders treatment
0,582  0,003  GABA C receptor agonist
0,530  0,002  NMDA receptor subunit 3A antagonist
0,511  0,005  Mcl-1 antagonist
0,506  0,005  Antiparkinsonian, rigidity relieving
0,527  0,034  Antibacterial
0,494  0,005  Antimigraine
0,482  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,469  0,005  Protein-tyrosine phosphatase inhibitor
0,495  0,034  5 Hydroxytryptamine release inhibitor
0,464  0,004  NMDA 2 receptor antagonist
0,455  0,003  NMDA 2A receptor antagonist
0,438  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,467  0,034  Antithrombotic
0,430  0,002  AMPA 4 receptor antagonist
0,470  0,044  Antiobesity
0,459  0,034  5 Hydroxytryptamine release stimulant
0,409  0,002  Kainate receptor 5 antagonist
0,416  0,010  Osteoarthritis treatment
0,441  0,037  Respiratory analeptic
0,417  0,028  Cardiovascular analeptic
0,385  0,007  Amyloid beta precursor protein antagonist
0,425  0,048  Thioredoxin glutathione reductase inhibitor
0,369  0,004  Excitatory amino acid transporter EAAC1 inhibitor
0,398  0,038  Analeptic
0,370  0,012  Tyrosine 3 hydroxylase inhibitor
0,424  0,066  Calcium channel L-type activator
0,381  0,033  Interleukin 2 agonist
0,349  0,008  Cell wall synthesis inhibitor
0,398  0,059  Ulceration
0,400  0,066  Antipruritic, allergic
0,362  0,029  Psychostimulant
0,338  0,012  Antiparkinsonian, tremor relieving
0,328  0,003  Kainate receptor antagonist
0,317  0,003  AMPA 2 receptor antagonist
0,350  0,036  Superoxide dismutase inhibitor
0,364  0,053  Antihypertensive
0,388  0,080  Analgesic, non-opioid
0,309  0,002  Kainate receptor 3 antagonist
0,331  0,032  5 Hydroxytryptamine uptake stimulant
0,299  0,002  Kainate receptor 1 antagonist
0,399  0,102  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,353  0,063  Cholesterol antagonist
0,331  0,042  Insulysin inhibitor
0,342  0,059  Vasodilator, coronary
0,353  0,073  Vasodilator, peripheral
0,298  0,021  Antiviral (Hepatitis)
0,278  0,002  Kainate receptor 4 antagonist
0,278  0,004  NMDA receptor subunit 3B antagonist
0,311  0,039  Dependence treatment
0,338  0,067  FMO1 substrate
0,364  0,094  Histamine release inhibitor
0,273  0,004  NMDA receptor agonist
0,302  0,035  Abortion inducer
0,306  0,042  DNA synthesis inhibitor
0,292  0,039  Gastrin inhibitor
0,314  0,062  Radioprotector
0,285  0,036  Antihypotensive
0,255  0,006  Glutamate receptor agonist
0,307  0,058  Antineurogenic pain
0,265  0,020  Antiviral (Hepatitis C)
0,276  0,036  DNA methyltransferase I inhibitor
0,247  0,009  Antispirochetal
0,289  0,054  Interleukin agonist
0,238  0,003  AMPA 1 receptor antagonist
0,237  0,003  Kainate receptor 2 antagonist
0,236  0,003  Glutamate (mGluR4) antagonist
0,253  0,020  Cholinergic antagonist
0,250  0,020  Acetylcholine antagonist
0,233  0,003  Glutamate (mGluR group III) antagonist
0,232  0,005  NMDA 2C receptor antagonist
0,260  0,035  Eye irritation, high
0,262  0,039  Sleep disorders treatment
0,261  0,039  Antialcoholic
0,263  0,042  DNA methylase inhibitor
0,235  0,014  Antismoking
0,242  0,022  UGT2B9 substrate
0,223  0,003  AMPA 3 receptor antagonist
0,251  0,035  Prostatic (benign) hyperplasia treatment
0,313  0,098  CYP2C9 substrate
0,314  0,103  GST A substrate
0,216  0,005  Human rhinovirus A protease inhibitor
0,240  0,029  Prostate disorders treatment
0,269  0,061  Cardiodepressant
0,206  0,005  Heat shock protein 70 antagonist
0,220  0,020  Antirickettsial
0,214  0,019  Ferrochelatase inhibitor
0,242  0,050  Antiviral (Influenza)
0,194  0,004  Nicotinic receptor alpha4 subunit antagonist
0,223  0,033  Acetylcholine M1 receptor antagonist
0,201  0,013  Adenylate cyclase stimulant
0,221  0,035  Succinate dehydrogenase inhibitor
0,260  0,076  Transcription factor STAT3 inhibitor
0,186  0,003  Glutamate (mGluR6) antagonist
0,196  0,014  GABA C receptor antagonist
0,218  0,038  Diuretic
0,215  0,036  Phospholipase C inhibitor
0,286  0,107  Calcium channel activator
0,214  0,038  Antiviral (Influenza A)
0,220  0,045  Lipocortins synthesis antagonist
0,264  0,089  FMO3 substrate
0,178  0,004  Glutamate (mGluR3) antagonist
0,254  0,080  Chemoprotective
0,178  0,005  AMPA receptor antagonist
0,185  0,014  Acetylcholine nicotinic antagonist
0,207  0,038  Skeletal muscle relaxant
0,297  0,132  TNF expression inhibitor
0,251  0,086  Transcription factor STAT inhibitor
0,177  0,016  Chronic obstructive bronchitis treatment
0,183  0,021  Sphingosine 1-phosphate receptor 5 antagonist
0,261  0,101  CYP2D6 substrate
0,171  0,012  Ca2+-transporting ATPase inhibitor
0,164  0,006  Nicotinic alpha4beta2 receptor antagonist
0,288  0,132  Rheumatoid arthritis treatment
0,157  0,002  Arginase inhibitor
0,160  0,006  Tourette's syndrome treatment
0,183  0,029  Acetylcholine muscarinic antagonist
0,223  0,072  Antiviral (West Nile virus)
0,163  0,011  Neuronal nicotinic receptor antagonist
0,177  0,026  Expectorant
0,193  0,042  Uterine stimulant
0,231  0,082  Teratogen
0,199  0,050  Antipruritic
0,159  0,011  Antidote, mercury
0,155  0,010  Antiprotozoal activity enhancer
0,247  0,103  GST M1-1 substrate
0,173  0,029  Aminopeptidase B inhibitor
0,164  0,021  Antiviral (Influenza B)
0,303  0,160  Cyclophilin D inhibitor
0,303  0,160  Antidiabetic
0,157  0,015  Acetylcholine nicotinic agonist
0,145  0,005  NMDA receptor glycine site agonist
0,162  0,023  Acetylcholine agonist
0,237  0,100  UGT2B4 substrate
0,154  0,018  Acetylcholine M3 receptor agonist
0,155  0,019  GABA C receptor rho-1 antagonist
0,257  0,121  Sodium/bile acid cotransporter inhibitor
0,137  0,002  Excitatory amino acid transporter 2 inhibitor
0,195  0,061  Macular degeneration treatment
0,270  0,138  GABA C receptor rho-3 antagonist
0,184  0,052  Neuropathy treatment
0,136  0,005  Angiotensin-converting enzyme inhibitor
0,223  0,093  Aldehyde oxidase inhibitor
0,158  0,028  Mucolytic
0,138  0,008  Glutamate (mGluR1) antagonist
0,143  0,014  CDC25A inhibitor
0,131  0,002  Kainate receptor agonist
0,178  0,051  Interferon gamma antagonist
0,146  0,021  Triose-phosphate isomerase inhibitor
0,173  0,049  Raynaud's phenomenon treatment
0,140  0,018  Glutamate dehydrogenase inhibitor
0,234  0,113  Antihypoxic
0,165  0,045  Cocaine dependence treatment
0,160  0,041  Cell adhesion inhibitor
0,148  0,030  Antineoplastic, alkylator
0,203  0,085  VCAM1 expression inhibitor
0,172  0,054  Attention deficit/hyperactivity disorder treatment
0,183  0,066  UGT1A4 substrate
0,229  0,112  Antiepileptic
0,207  0,090  Peptidyltransferase inhibitor
0,221  0,104  UGT1A9 substrate
0,128  0,014  Glycine receptor antagonist
0,119  0,005  Nicotinic alpha3beta2 receptor antagonist
0,165  0,052  Hemostatic
0,168  0,056  Thiol protease inhibitor
0,201  0,091  Embryotoxic
0,135  0,026  Electrolyte absorption antagonist
0,142  0,034  Protease inhibitor
0,139  0,031  Adenylate kinase inhibitor
0,170  0,063  Neurotensin receptor agonist
0,110  0,005  Antihemophilic
0,114  0,008  Phospholipase D inhibitor
0,176  0,071  Muscle relaxant
0,133  0,030  Prolactin inhibitor
0,155  0,054  Calcium channel blocker
0,168  0,067  Arachidonic acid antagonist
0,133  0,033  HIV-1 integrase (Overall Integration) inhibitor
0,167  0,067  Anticoagulant
0,110  0,010  Nicotinic receptor alpha7 subunit antagonist
0,121  0,023  Somatostatin 1 agonist
0,174  0,075  Male reproductive disfunction treatment
0,118  0,020  Aminopeptidase I inhibitor
0,101  0,004  NMDA 2D receptor antagonist
0,212  0,114  Flavin-containing monooxygenase substrate
0,133  0,036  UDP-glucose 4-epimerase inhibitor
0,100  0,004  Dipeptidyl peptidase I inhibitor
0,193  0,100  Nitric-oxide synthase stimulant
0,208  0,115  Immunostimulant
0,165  0,072  Irritable Bowel syndrome treatment
0,109  0,017  Argininosuccinate synthase inhibitor
0,154  0,062  Amylase inhibitor
0,158  0,067  Phospholipase A2 inhibitor
0,158  0,066  Antiischemic, cerebral
0,097  0,007  Alpha-mannosidase inhibitor
0,117  0,028  Antibiotic
0,174  0,086  Platelet adhesion inhibitor
0,117  0,030  NADH dehydrogenase inhibitor
0,181  0,094  Insulin sensitizer
0,205  0,118  Antipsychotic
0,169  0,083  Antipruritic, non-allergic
0,160  0,074  Thrombolytic
0,163  0,077  UGT2B10 substrate
0,164  0,078  UGT2B7 substrate
0,100  0,015  Androgen agonist
0,124  0,039  Potassium channel (Ca-activated) activator
0,090  0,007  Mannosidase inhibitor
0,232  0,149  CYP3A4 substrate
0,093  0,010  Dipeptidyl peptidase inhibitor
0,095  0,014  Glutamate (mGluR7) antagonist
0,084  0,003  Glutamate (mGluR8) antagonist
0,125  0,045  Antischistosomal
0,128  0,048  Calcium channel (voltage-sensitive) blocker
0,087  0,008  Somatostatin 4 agonist
0,119  0,041  GST T1-1 substrate
0,191  0,113  RNA-directed DNA polymerase inhibitor
0,105  0,027  Glutamate decarboxylase inhibitor
0,085  0,008  Dihydroorotase inhibitor
0,106  0,030  Phosphofructokinase-1 inhibitor
0,176  0,101  Pneumotoxic
0,146  0,071  Protein kinase stimulant
0,179  0,105  Angiogenesis stimulant
0,145  0,072  Hair growth stimulant
0,087  0,015  Dopamine transporter inhibitor
0,185  0,113  Urologic disorders treatment
0,092  0,020  Alcohol oxidase inhibitor
0,148  0,076  Insulin secretagoues
0,095  0,024  Glycine receptor agonist
0,075  0,004  Phenylethanolamine N methyltransferase inhibitor
0,082  0,012  Nicotinic receptor alpha3 subunit antagonist
0,076  0,007  Dopamine D5 agonist
0,089  0,021  CDC25B inhibitor
0,150  0,082  Carcinogenic, group 1
0,071  0,003  Glutamate (mGluR3) agonist
0,119  0,051  Antiviral (Poxvirus)
0,117  0,049  DOPA decarboxylase inhibitor
0,089  0,022  Biliverdin reductase inhibitor
0,091  0,024  MAP kinase kinase 7 inhibitor
0,102  0,035  Porphobilinogen synthase inhibitor
0,080  0,014  Aconitate hydratase inhibitor
0,090  0,024  Carbamoyl phosphate synthetase inhibitor
0,074  0,009  Dipeptidyl peptidase IV inhibitor
0,126  0,061  Antitussive
0,084  0,020  SULT2A1 substrate
0,160  0,096  Sensitization
0,076  0,012  Prolyl endopeptidase inhibitor
0,067  0,004  Tryptophan 5 hydroxylase inhibitor
0,165  0,102  UGT1A1 substrate
0,118  0,055  Myasthenia Gravis treatment
0,122  0,060  Antifungal (Pneumocystis)
0,074  0,013  HCV NS3/NS4A protease inhibitor
0,090  0,029  Potassium channel large-conductance Ca-activated activator
0,143  0,083  Cholinergic
0,066  0,007  Guanylate cyclase inhibitor
0,086  0,027  Anticholelithogenic
0,061  0,004  Nicotinic alpha4beta2 receptor agonist
0,109  0,051  Anabolic
0,101  0,044  Restless leg syndrome treatment
0,061  0,004  Nicotinic alpha3beta4 receptor agonist
0,066  0,010  Factor XIa inhibitor
0,240  0,184  CYP2C19 inhibitor
0,070  0,014  5 Hydroxytryptamine 2C agonist
0,073  0,017  Acetylcholine M2 receptor agonist
0,059  0,004  Glutamate (mGluR1) agonist
0,065  0,011  Nicotinic receptor beta4 subunit antagonist
0,086  0,032  GABA B receptor agonist
0,084  0,031  Elastase 1 inhibitor
0,106  0,053  Creatine kinase inhibitor
0,088  0,036  Narcotic antagonist
0,061  0,010  Membrane dipeptidase inhibitor
0,157  0,106  Anesthetic general
0,098  0,047  Ornithine decarboxylase inhibitor
0,089  0,038  Acetylcholine M4 receptor antagonist
0,117  0,067  Calcium channel N-type blocker
0,084  0,034  Prokinetic
0,115  0,066  Microtubule formation inhibitor
0,058  0,010  Hypogonadism treatment
0,083  0,035  Phenylalanine 4-hydroxylase inhibitor
0,056  0,008  Integrin alpha2 antagonist
0,059  0,011  Glutamate (mGluR group II) antagonist
0,138  0,091  GABA C receptor rho-2 antagonist
0,191  0,145  Antidiabetic (type 2)
0,078  0,031  Acetylcholine M2 receptor antagonist
0,086  0,041  Analgesic, opioid
0,054  0,009  Glutamate (mGluR8) agonist
0,073  0,028  Dopamine uptake inhibitor
0,086  0,042  Keratolytic
0,071  0,027  Acetylcholine muscarinic agonist
0,069  0,026  Ornithine carbamoyltransferase inhibitor
0,069  0,025  Prolactin release inhibitor
0,090  0,047  Inducible nitric-oxide synthase inhibitor
0,073  0,030  Acetylcholine M3 receptor antagonist
0,137  0,094  Urinary incontinence treatment
0,064  0,024  Myc inhibitor
0,100  0,060  Antifibrinolytic
0,138  0,099  Movement disorders treatment
0,063  0,023  Adenine nucleotide translocase inhibitor
0,093  0,055  Glutamate release inhibitor
0,070  0,032  Antiviral (Parainfluenza)
0,082  0,044  Antidote, organophosphates
0,167  0,130  UGT1A6 substrate
0,041  0,004  Nicotinic alpha4 receptor agonist
0,176  0,140  Spasmolytic
0,130  0,093  Antidote
0,150  0,113  UDP-glucuronosyltransferase substrate
0,042  0,005  Integrin alpha2beta1 antagonist
0,170  0,134  5 Hydroxytryptamine 3E antagonist
0,108  0,071  Protein-tyrosine phosphatase 1B inhibitor
0,068  0,033  Acetylcholine M5 receptor antagonist
0,039  0,004  Antibiotic Quinolone-like
0,073  0,038  Gaucher disease treatment
0,097  0,062  UGT2B11 substrate
0,179  0,144  Antiosteoporotic
0,065  0,030  Acyl-CoA dehydrogenase inhibitor
0,078  0,044  Histidine decarboxylase inhibitor
0,049  0,016  GABA uptake inhibitor
0,121  0,088  Antifungal enhancer
0,064  0,032  Nicotinic neuronal receptor agonist
0,170  0,139  Myocardial infarction treatment
0,055  0,024  CC chemokine receptor 2B antagonist
0,090  0,060  Actinic keratosis treatment
0,050  0,020  Baculoviral IAP repeat-containing protein inhibitor
0,078  0,049  GABA aminotransferase inhibitor
0,066  0,037  Antimycoplasmal
0,039  0,011  Lysine carboxypeptidase inhibitor
0,035  0,006  GRP78 expression inhibitor
0,162  0,133  NOS2 expression inhibitor
0,037  0,009  NMDA receptor glycine site antagonist
0,048  0,020  5-Alpha-reductase inhibitor
0,201  0,173  CTGF expression inhibitor
0,100  0,073  Choleretic
0,107  0,080  Carcinogenic, group 3
0,034  0,007  Glutamate (mGluR1a) agonist
0,064  0,039  Neuraminidase inhibitor
0,161  0,136  Antihypercholesterolemic
0,034  0,009  Antibiotic Naphthyridine-like
0,061  0,037  Sphingosine kinase inhibitor
0,126  0,102  Antidiabetic (type 1)
0,120  0,096  Sphingosine 1-phosphate receptor 2 antagonist
0,029  0,005  Neuraminidase (Influenza B) inhibitor
0,098  0,074  UGT2B1 substrate
0,070  0,047  Protein kinase C beta inhibitor
0,112  0,089  Antihyperlipoproteinemic
0,032  0,009  5-Alpha-reductase 2 inhibitor
0,119  0,096  UGT2B15 substrate
0,033  0,010  Nicotinic acid receptor 2 antagonist
0,029  0,006  GABA transporter inhibitor
0,080  0,058  Adrenaline agonist
0,058  0,035  Bombesin 3 receptor antagonist
0,078  0,056  Chymotrypsin inhibitor
0,037  0,016  GABA transporter 3 inhibitor
0,053  0,032  Anesthetic inhalation
0,111  0,091  Sphingosine 1-phosphate receptor 4 antagonist
0,024  0,004  Tryptophan hydroxylase 1 inhibitor
0,039  0,019  AMPA receptor agonist
0,119  0,099  Antieczematic
0,057  0,038  Peristaltic stimulant
0,122  0,103  SULT1A3 substrate
0,178  0,160  CYP2C19 substrate
0,034  0,016  Glutamate (mGluR2) antagonist
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,055  0,038  Glucosylceramidase inhibitor
0,125  0,108  UGT1A3 substrate
0,023  0,006  Complement factor D inhibitor
0,173  0,156  Huntington's disease treatment
0,035  0,019  Dipeptidyl peptidase II inhibitor
0,063  0,047  Protease 3C (Human rhinovirus) inhibitor
0,033  0,018  Epoxide hydrolase 1 inhibitor
0,062  0,046  5 Hydroxytryptamine 3 agonist
0,060  0,045  Adrenaline uptake inhibitor
0,036  0,022  Fumarate hydratase inhibitor
0,044  0,029  Acetylcholine M1 receptor agonist
0,018  0,004  Glutamate (mGluR6) agonist
0,034  0,021  Carboxypeptidase B inhibitor
0,155  0,143  Cyclic AMP phosphodiesterase inhibitor
0,082  0,070  Granulocyte macrophage colony stimulating factor agonist
0,046  0,034  Antibiotic Glycopeptide-like
0,106  0,094  Cyclooxygenase 3 inhibitor
0,059  0,047  5 Hydroxytryptamine 2A agonist
0,092  0,079  Glutamate (mGluR7) agonist
0,068  0,056  Calcium channel L-type blocker
0,131  0,119  Diabetic retinopathy treatment
0,101  0,090  Antineoplastic antimetabolite
0,044  0,033  Neuraminidase (Influenza A) inhibitor
0,053  0,042  Dihydroorotate oxidase inhibitor
0,032  0,021  Somatostatin agonist
0,099  0,089  Cholesterol synthesis inhibitor
0,106  0,096  Cathepsin H inhibitor
0,056  0,046  CXC chemokine 4 receptor antagonist
0,183  0,173  NOS3 expression inhibitor
0,015  0,005  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,017  0,007  GABA transporter 1 inhibitor
0,157  0,147  Vasodilator
0,094  0,085  Cystathionine beta-synthase inhibitor
0,020  0,011  5-Alpha-reductase 1 inhibitor
0,157  0,150  VEGF expression inhibitor
0,040  0,033  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,030  0,024  Caspase 2 inhibitor
0,111  0,106  Acaricide
0,024  0,020  Vanilloid 2 agonist
0,104  0,100  Contraceptive female
0,087  0,082  Sulfotransferase substrate
0,086  0,082  Antithrombocytopenic
0,085  0,082  Antiemetic
0,015  0,012  Antibiotic Tetracycline-like
0,038  0,036  Sphingosine kinase 1 inhibitor
0,101  0,099  CNS active muscle relaxant
0,031  0,029  Glutamate (mGluR group II) agonist
0,054  0,052  Antidote, heavy metal
0,031  0,029  ADAM10 endopeptidase inhibitor
0,025  0,024  Baculoviral IAP repeat-containing protein 4 inhibitor
0,004  0,003  Antibiotic Carbapenem-like
0,059  0,057  Neuraminidase (influenza) inhibitor
0,169  0,168  Amyotrophic lateral sclerosis treatment
0,040  0,039  Plasmin inhibitor
0,011  0,010  Integrin beta2 antagonist
0,031  0,030  Factor XI inhibitor
0,086  0,086  Nitric-oxide synthase inhibitor
0,126  0,126  MAP kinase kinase 4 inhibitor
0,057  0,057  Heme oxygenase stimulant
0,008  0,008  Folate transporter 1 inhibitor

